Krishnan A, Garg R, Kahandaliyanage A. Hypertension in the South-East Asia Region: an overview. Regional Health Forum 2013;17:7-14
Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hyper- tension. J Hypertens 2003;21:1983-92.
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25:1751-62.
National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Inter- net]. London: Royal College of Physicians (UK); 2011 Aug.
Thai Hypertension Society Writing Group. Thai Guide- lines on the treatment of hypertension update 2012. (Accessed January, 2013, at http://www.thaihypertension. org/files/ 216_1.Hypertension_Guideline_2012.pdf.)
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ ESC Guidelines for the management of arterial hyper- tension: the Task Force for the management ofarterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panelmembers appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507-20.
Rungtanapirom S, Khankam J, Benjakhunprasit N, et al. Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months’ Experience. Bangkok Med J 2013;5:1-8. (Accessed January 10, 2015 at http://www. bangkokmedjournal.com/sites/default/files/fullpapers/ TBMJ-Vol5-1.pdf).
Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults: the inter- national collaborative study of cardiovascular disease in Asia. Diabetes Care 2003;26:2758-63.
Buranakitjaroen P1. Hypertension audit in clinical practice based in Thailand (HABIT). J Med Assoc Thai 2011;94:S57-65.
Igho-Pemu P, Quarshie A, Oduwole A, et al. Morehouse Community Physicians Network (CPN) hypertension registry:patterns of care and opportunities for targeted medical education. Ethn Dis 2005;15:S5-120-3.
Kubozono T, Miyata M, Ueyama K, et al. Clinical signi- ficance and reproducibility of new arterial distensibility index. Circ J 2007;71:89-94.
Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007;71:1710-4.
Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 2007;30:335-40.
Sakane K, Miyoshi T, Doi M, et al. Association of new arterial stiffness parameter, the cardio-ankle vascular index, withleftventriculardiastolicfunction. JAtheroscler Thromb 2008;15:261-8.
Satoh N, Shimatsu A, Kato Y, et al. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res 2008;31:1921-30.
Nakamura K, Tomaru T, Yamamura S, et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J 2008;72:598-604.
Yingchoncharoen T, Limpijankit T, Jongjirasiri S, et al. Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA- EGAT score). Heart Asia 2012;4:77-82.
Franklin SS. Arterial stiffness and hypertension: a two- way street? Hypertension 2005;45:349-51.
Jensen JS, Feldt-Rasmussen B, Strandgaard S, et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000;35:898-903.
Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice. Int J Clin Pract 2008;62:97-108.
Nakamura S, Kawano Y, Inenaga T, et al. Microalbumin- uria and Cardiovascular Events in Elderly Hypertensive Patients without Previous Cardiovascular Complications. Hypertens Res 2003;26:603-8.
Mettimano M, Specchia ML, Migneco A, et al. Microal- buminuria as a marker of cardiac damage in essential hypertension. Eur Rev Med Pharmacol Sci 2001;5:31-6.
Pontremoli R, Leoncini G, Ravera M, et al. Microalbu- minuria, cardiovascular, and renal risk in primary hyper- tension. J Am Soc Nephrol 2002;13:S169-72.
Palatini P. Microalbuminuria in hypertension. Curr Hypertens Rep 2003;5:208-14.
Wachtell K, Ibsen H, Olsen MH, et al. Albuminuria and cardiovascular risk in HypertensivePatients with Left Ventricular Hypertrophy: the LIFE study. Ann Intern Med 2003;139:901-6.
Viazzi F, Leoncini G, Conti N, et al. Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin J Am Soc Nephrol 2010;5:1099-106.
S Jalal, FA Sofi, MS Alai, et al. Prevalence of microalbu- minuria in essential hypertension: A study of patients with mild to moderate hypertension. Indian J Nephrol 2001;11:6-11.
Buranakitjaroen P, Phoocharoenchanachai M, Saravich S. Microalbuminuria in Thai Essential Hypertension Patients. J Int Med Res 2007;35:836-47.
Pruijm MT1, Madeleine G, Riesen WF, et al. Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens 2008;26:871-7.
Tebbe U, Bramlage P, Thoenes M, et al. Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med Wkly 2009;139:473-80.
Gojaseni P, Phaopha A, Chailimpamontree W, et al. Preva- lence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients. Vasc Health Risk Manag 2010;6:157-65.
Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta- analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300.
Corrao G , Parodi A, Zambon A, et al. Reduced discon- tinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens 2010;28:1584-90.
Egan BM , Bandyopadhyay D, Shaftman SR, et al. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension 2012;59:1124-31.
